CompoAtlas

Menopause

Menopause, licence 80091014: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Mill Bay Menopause
Licence holder
Ebysu Nutrition, a division of ID tagged inc.
NPN or DIN-HM
80091014
Status
Active licence
Licence date
27 February 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Piper nigrum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 50:1

Dry plant equivalent : 125 mg

Potency : 95.0 % Piperine

2.5 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Silice, Hypromellose, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)1.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Source of antioxidants/Provides antioxidants. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to support/promote healthy estrogen metabolism/balance. Helps reduce the severity and duration of symptoms associated with recurrent breast pain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80091014

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line